Neville J Anthony

USPTO Granted Patents = 69 (Patent Applications = 16)

EPO Patents = 14 (Patent Applications = 14)

Average Co-Inventor Count = 4.0

ph-index = 21

Forward Citations = 1,598(Granted Patents)

Forward Citations (Not Self Cited) = 1,571(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Hatfield, PA (US) (1994 - 2005)
Chalfont, PA (US) (2005 - 2013)
Northborough, MA (US) (2013 - 2024)

Company Filing History:

Merck Sharp + Dohme Corp.

Foghorn Therapeutics Inc.

Revolution Medicines, Inc.

where one patent can have more than one assignee

Years Active: 1994-2025

Loading Chart...

Areas of Expertise:

Protoporphyrinogen Oxidase Inhibitors

RORgamma Inhibitors

Human Phosphatidylinositol 3-Kinase Delta

Spleen Tyrosine Kinase Inhibitors

Beta 3 Adrenergic Receptor Agonists

HIV Integrase Inhibitors

Bradykinin Antagonists

Prenyl-Protein Transferase Inhibitors

Farnesyl-Protein Transferase Inhibitors

Amino-Pyridine Compounds

Bicyclic Compounds

69 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12509453 - BRM/BRG1 inhibitors and uses thereof (2025-12-30),

2. 12383560 - Compounds and uses thereof (2025-08-12),

3. 12302900 - Protoporphyrinogen oxidase inhibitors (2025-05-20),

4. 11889833 - Protoporphyrinogen oxidase inhibitors (2024-02-06),

5. 11827610 - Protoporphyrinogen oxidase inhibitors (2023-11-28),

6. 11497752 - Compounds and uses thereof (2022-11-15),

7. 10948495 - Methods and reagents for analyzing protein-protein interfaces (2021-03-16),

8. 10745364 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease (2020-08-18),

9. 10466249 - Methods and reagents for analyzing protein-protein interfaces (2019-11-05),

10. 10221146 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease (2019-03-05),

11. 10196354 - 4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof (2019-02-05),

12. 10100064 - Purine inhibitors of human phosphatidylinositol 3-kinase delta (2018-10-16),

13. 10039839 - Compounds that participate in cooperative binding and uses thereof (2018-08-07),

14. 9989535 - Methods and reagents for analyzing protein-protein interfaces (2018-06-05),

15. 9938281 - Purine inhibitors of human phosphatidylinositol 3-kinase delta (2018-04-10),

Title: Neville J Anthony: A Visionary Inventor Shaping Tomorrow's World

Introduction:

Neville J Anthony is a trailblazing inventor based in Hatfield, PA, whose relentless pursuit of innovation has led to groundbreaking contributions in the field of science and technology. With an impressive portfolio of 64 patents, Anthony continues to redefine the boundaries of what is achievable through his remarkable creativity and ingenuity.

Latest Patents:

Among his latest patents is "Compounds and Uses Thereof," showcasing his expertise in developing compounds specifically designed for treating BAF complex-related disorders. Additionally, Anthony's patent on "Methods and Reagents for Analyzing Protein-Protein Interfaces" highlights his novel approaches to studying protein interactions, particularly between intracellular and mammalian proteins.

Career Highlights:

Having worked at renowned companies such as Merck & Company, Inc. and Merck Sharp & Dohme Corporation, Neville J Anthony has left an indelible mark on the industry with his innovative solutions and pioneering spirit. His dedication to advancing scientific knowledge and pushing the boundaries of traditional research has earned him recognition as a true pioneer in his field.

Collaborations:

Throughout his illustrious career, Neville J Anthony has collaborated with esteemed professionals, including colleagues like Robert P Gomez and Kenneth Jay Barr. These collaborative efforts have not only enhanced his own work but have also contributed to the collective progress of the scientific community, further solidifying Anthony's reputation as a visionary inventor.

Conclusion:

In conclusion, Neville J Anthony's exceptional talents and unwavering commitment to innovation have positioned him as a true pioneer in the world of inventions. His remarkable contributions continue to inspire and shape the future of scientific discovery, leaving an enduring legacy that will undoubtedly influence generations to come.

This text is generated by artificial intelligence and may not be accurate.